Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Psychedelic Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
F Hoffmann-La Roche Ltd
Mind Medicine, Inc
Hikma Pharmaceuticals PLC
EmpathBio
Avadel
Compass Pathways
Pfizer Inc
DemeRx
Jazz Pharmaceuticals, Inc
GABA Therapeutics, Inc
NeuroRx, Inc
Janssen Pharmaceuticals
By Type:
LSD
DMT
Psilocybin
Ketamine
Others
MDMA
By Application:
Substance Abuse Disorders
Others
Depressive Disorders
Post-Traumatic Stress Disorders
Obsessive Compulsive Disorders
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Psychedelic Drugs Market Overview 2018-2029
-
1.1 China Psychedelic Drugs Industry Development Overview
-
1.2 China Psychedelic Drugs Industry Development History
-
1.3 China Psychedelic Drugs Industry Market Size (2018-2029)
-
1.4 China Psychedelic Drugs Market Analysis by Type from Production Side
-
1.4.1 China Psychedelic Drugs Production Volume, Production Value and Growth Rate of LSD (2018-2029)
-
1.4.2 China Psychedelic Drugs Production Volume, Production Value and Growth Rate of DMT (2018-2029)
-
1.4.3 China Psychedelic Drugs Production Volume, Production Value and Growth Rate of Psilocybin (2018-2029)
-
1.4.4 China Psychedelic Drugs Production Volume, Production Value and Growth Rate of Ketamine (2018-2029)
-
1.4.5 China Psychedelic Drugs Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.6 China Psychedelic Drugs Production Volume, Production Value and Growth Rate of MDMA (2018-2029)
-
1.5 China Psychedelic Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Psychedelic Drugs Sales Volume, Sales Value and Growth Rate of Substance Abuse Disorders (2018-2029)
-
1.5.2 China Psychedelic Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.3 China Psychedelic Drugs Sales Volume, Sales Value and Growth Rate of Depressive Disorders (2018-2029)
-
1.5.4 China Psychedelic Drugs Sales Volume, Sales Value and Growth Rate of Post-Traumatic Stress Disorders (2018-2029)
-
1.5.5 China Psychedelic Drugs Sales Volume, Sales Value and Growth Rate of Obsessive Compulsive Disorders (2018-2029)
-
1.6 China Psychedelic Drugs Market Analysis by Region
-
1.6.1 North China Psychedelic Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Psychedelic Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Psychedelic Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Psychedelic Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Psychedelic Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Psychedelic Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Psychedelic Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Psychedelic Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Psychedelic Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Psychedelic Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Psychedelic Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Psychedelic Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Psychedelic Drugs Industry Development
Chapter 3 Psychedelic DrugsIndustry Chain Analysis
-
3.1 Psychedelic Drugs Industry Chain
-
3.2 Psychedelic Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Psychedelic Drugs Market
-
3.3 Psychedelic Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Psychedelic Drugs Market
Chapter 4 China Psychedelic Drugs Market, by Type
-
4.1 China Psychedelic Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Psychedelic Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Psychedelic Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Psychedelic Drugs Production Volume and Growth Rate of LSD
-
4.5.2 China Psychedelic Drugs Production Volume and Growth Rate of DMT
-
4.5.3 China Psychedelic Drugs Production Volume and Growth Rate of Psilocybin
-
4.5.4 China Psychedelic Drugs Production Volume and Growth Rate of Ketamine
-
4.5.5 China Psychedelic Drugs Production Volume and Growth Rate of Others
-
4.5.6 China Psychedelic Drugs Production Volume and Growth Rate of MDMA
Chapter 5 China Psychedelic Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Psychedelic Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Psychedelic Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Psychedelic Drugs Market Size and Growth Rate of Substance Abuse Disorders
-
5.5.2 China Psychedelic Drugs Market Size and Growth Rate of Others
-
5.5.3 China Psychedelic Drugs Market Size and Growth Rate of Depressive Disorders
-
5.5.4 China Psychedelic Drugs Market Size and Growth Rate of Post-Traumatic Stress Disorders
-
5.5.5 China Psychedelic Drugs Market Size and Growth Rate of Obsessive Compulsive Disorders
Chapter 6 China Psychedelic Drugs Market, by Region
-
6.1 China Psychedelic Drugs Production Volume and Production Value, by Region
-
6.2 China Psychedelic Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Psychedelic Drugs Market Analysis
-
7.1 North China Psychedelic Drugs Market, by Type
-
7.2 North China Psychedelic Drugs Market, by Application
Chapter 8 Central China Psychedelic Drugs Market Analysis
-
8.1 Central China Psychedelic Drugs Market, by Type
-
8.2 Central China Psychedelic Drugs Market, by Application
Chapter 9 South China Psychedelic Drugs Market Analysis
-
9.1 South China Psychedelic Drugs Market, by Type
-
9.2 South China Psychedelic Drugs Market, by Application
Chapter 10 East China Psychedelic Drugs Market Analysis
-
10.1 East China Psychedelic Drugs Market, by Type
-
10.2 East China Psychedelic Drugs Market, by Application
Chapter 11 Northeast China Psychedelic Drugs Market Analysis
-
11.1 Northeast China Psychedelic Drugs Market, by Type
-
11.2 Northeast China Psychedelic Drugs Market, by Application
Chapter 12 Southwest China Psychedelic Drugs Market Analysis
-
12.1 Southwest China Psychedelic Drugs Market, by Type
-
12.2 Southwest China Psychedelic Drugs Market, by Application
Chapter 13 Northwest China Psychedelic Drugs Market Analysis
-
13.1 Northwest China Psychedelic Drugs Market, by Type
-
13.2 Northwest China Psychedelic Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 F Hoffmann-La Roche Ltd
-
14.1.1 F Hoffmann-La Roche Ltd Company Profile
-
14.1.2 F Hoffmann-La Roche Ltd Psychedelic Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Mind Medicine, Inc
-
14.2.1 Mind Medicine, Inc Company Profile
-
14.2.2 Mind Medicine, Inc Psychedelic Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Hikma Pharmaceuticals PLC
-
14.3.1 Hikma Pharmaceuticals PLC Company Profile
-
14.3.2 Hikma Pharmaceuticals PLC Psychedelic Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 EmpathBio
-
14.4.1 EmpathBio Company Profile
-
14.4.2 EmpathBio Psychedelic Drugs Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Avadel
-
14.5.1 Avadel Company Profile
-
14.5.2 Avadel Psychedelic Drugs Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Compass Pathways
-
14.6.1 Compass Pathways Company Profile
-
14.6.2 Compass Pathways Psychedelic Drugs Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Pfizer Inc
-
14.7.1 Pfizer Inc Company Profile
-
14.7.2 Pfizer Inc Psychedelic Drugs Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 DemeRx
-
14.8.1 DemeRx Company Profile
-
14.8.2 DemeRx Psychedelic Drugs Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Jazz Pharmaceuticals, Inc
-
14.9.1 Jazz Pharmaceuticals, Inc Company Profile
-
14.9.2 Jazz Pharmaceuticals, Inc Psychedelic Drugs Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 GABA Therapeutics, Inc
-
14.10.1 GABA Therapeutics, Inc Company Profile
-
14.10.2 GABA Therapeutics, Inc Psychedelic Drugs Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 NeuroRx, Inc
-
14.11.1 NeuroRx, Inc Company Profile
-
14.11.2 NeuroRx, Inc Psychedelic Drugs Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Janssen Pharmaceuticals
-
14.12.1 Janssen Pharmaceuticals Company Profile
-
14.12.2 Janssen Pharmaceuticals Psychedelic Drugs Market Performance
-
14.12.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Psychedelic Drugs Industry Research Conclusions
-
15.2 Psychedelic Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Psychedelic Drugs Industry Market Size (2018-2029)
-
Figure China Psychedelic Drugs Production Volume, Production Value and Growth Rate of LSD (2018-2029)
-
Figure China Psychedelic Drugs Production Volume, Production Value and Growth Rate of DMT (2018-2029)
-
Figure China Psychedelic Drugs Production Volume, Production Value and Growth Rate of Psilocybin (2018-2029)
-
Figure China Psychedelic Drugs Production Volume, Production Value and Growth Rate of Ketamine (2018-2029)
-
Figure China Psychedelic Drugs Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Psychedelic Drugs Production Volume, Production Value and Growth Rate of MDMA (2018-2029)
-
Figure China Psychedelic Drugs Sales Volume, Sales Value and Growth Rate of Substance Abuse Disorders (2018-2029)
-
Figure China Psychedelic Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China Psychedelic Drugs Sales Volume, Sales Value and Growth Rate of Depressive Disorders (2018-2029)
-
Figure China Psychedelic Drugs Sales Volume, Sales Value and Growth Rate of Post-Traumatic Stress Disorders (2018-2029)
-
Figure China Psychedelic Drugs Sales Volume, Sales Value and Growth Rate of Obsessive Compulsive Disorders (2018-2029)
-
Figure North China Psychedelic Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Psychedelic Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Psychedelic Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Psychedelic Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Psychedelic Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Psychedelic Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Psychedelic Drugs Market Size and Growth Rate from 2018-2029
-
Figure Psychedelic Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Psychedelic Drugs Market Share by Type in 2018
-
Figure China Psychedelic Drugs Market Share by Type in 2023
-
Figure China Psychedelic Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Psychedelic Drugs Production Volume and Growth Rate of LSD (2018-2023)
-
Figure China Psychedelic Drugs Production Volume and Growth Rate of DMT (2018-2023)
-
Figure China Psychedelic Drugs Production Volume and Growth Rate of Psilocybin (2018-2023)
-
Figure China Psychedelic Drugs Production Volume and Growth Rate of Ketamine (2018-2023)
-
Figure China Psychedelic Drugs Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Psychedelic Drugs Production Volume and Growth Rate of MDMA (2018-2023)
-
Figure China Psychedelic Drugs Market Share by Application in 2018
-
Figure China Psychedelic Drugs Market Share by Application in 2023
-
Figure China Psychedelic Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Psychedelic Drugs Market Size and Growth Rate of Substance Abuse Disorders (2018-2023)
-
Figure China Psychedelic Drugs Market Size and Growth Rate of Others (2018-2023)
-
Figure China Psychedelic Drugs Market Size and Growth Rate of Depressive Disorders (2018-2023)
-
Figure China Psychedelic Drugs Market Size and Growth Rate of Post-Traumatic Stress Disorders (2018-2023)
-
Figure China Psychedelic Drugs Market Size and Growth Rate of Obsessive Compulsive Disorders (2018-2023)
-
Table China Psychedelic Drugs Production Volume by Region (2018-2023)
-
Table China Psychedelic Drugs Production Volume Share by Region (2018-2023)
-
Figure China Psychedelic Drugs Production Volume Share by Region (2018-2023)
-
Table China Psychedelic Drugs Production Value by Region (2018-2023)
-
Table China Psychedelic Drugs Production Value Share by Region (2018-2023)
-
Figure China Psychedelic Drugs Production Value Share by Region (2018-2023)
-
Table China Psychedelic Drugs Sales Volume by Region (2018-2023)
-
Table China Psychedelic Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Psychedelic Drugs Sales Volume Share by Region (2018-2023)
-
Table China Psychedelic Drugs Sales Value by Region (2018-2023)
-
Table China Psychedelic Drugs Sales Value Share by Region (2018-2023)
-
Figure China Psychedelic Drugs Sales Value Share by Region (2018-2023)
-
Table North China Psychedelic Drugs Production Volume by Type (2018-2023)
-
Table North China Psychedelic Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Psychedelic Drugs Production Volume Share by Type (2018-2023)
-
Table North China Psychedelic Drugs Sales Volume by Application (2018-2023)
-
Table North China Psychedelic Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Psychedelic Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Psychedelic Drugs Production Volume by Type (2018-2023)
-
Table Central China Psychedelic Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Psychedelic Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Psychedelic Drugs Sales Volume by Application (2018-2023)
-
Table Central China Psychedelic Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Psychedelic Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Psychedelic Drugs Production Volume by Type (2018-2023)
-
Table South China Psychedelic Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Psychedelic Drugs Production Volume Share by Type (2018-2023)
-
Table South China Psychedelic Drugs Sales Volume by Application (2018-2023)
-
Table South China Psychedelic Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Psychedelic Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Psychedelic Drugs Production Volume by Type (2018-2023)
-
Table East China Psychedelic Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Psychedelic Drugs Production Volume Share by Type (2018-2023)
-
Table East China Psychedelic Drugs Sales Volume by Application (2018-2023)
-
Table East China Psychedelic Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Psychedelic Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Psychedelic Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Psychedelic Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Psychedelic Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Psychedelic Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Psychedelic Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Psychedelic Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Psychedelic Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Psychedelic Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Psychedelic Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Psychedelic Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Psychedelic Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Psychedelic Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Psychedelic Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Psychedelic Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Psychedelic Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Psychedelic Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Psychedelic Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Psychedelic Drugs Sales Volume Share by Application (2018-2023)
-
Table F Hoffmann-La Roche Ltd Company Profile
-
Table F Hoffmann-La Roche Ltd Psychedelic Drugs Revenue, Price and Gross (2018-2023)
-
Table Mind Medicine, Inc Company Profile
-
Table Mind Medicine, Inc Psychedelic Drugs Revenue, Price and Gross (2018-2023)
-
Table Hikma Pharmaceuticals PLC Company Profile
-
Table Hikma Pharmaceuticals PLC Psychedelic Drugs Revenue, Price and Gross (2018-2023)
-
Table EmpathBio Company Profile
-
Table EmpathBio Psychedelic Drugs Revenue, Price and Gross (2018-2023)
-
Table Avadel Company Profile
-
Table Avadel Psychedelic Drugs Revenue, Price and Gross (2018-2023)
-
Table Compass Pathways Company Profile
-
Table Compass Pathways Psychedelic Drugs Revenue, Price and Gross (2018-2023)
-
Table Pfizer Inc Company Profile
-
Table Pfizer Inc Psychedelic Drugs Revenue, Price and Gross (2018-2023)
-
Table DemeRx Company Profile
-
Table DemeRx Psychedelic Drugs Revenue, Price and Gross (2018-2023)
-
Table Jazz Pharmaceuticals, Inc Company Profile
-
Table Jazz Pharmaceuticals, Inc Psychedelic Drugs Revenue, Price and Gross (2018-2023)
-
Table GABA Therapeutics, Inc Company Profile
-
Table GABA Therapeutics, Inc Psychedelic Drugs Revenue, Price and Gross (2018-2023)
-
Table NeuroRx, Inc Company Profile
-
Table NeuroRx, Inc Psychedelic Drugs Revenue, Price and Gross (2018-2023)
-
Table Janssen Pharmaceuticals Company Profile
-
Table Janssen Pharmaceuticals Psychedelic Drugs Revenue, Price and Gross (2018-2023)
-
